Publications
Export 115 results:
Auteur Title [ Type
Filtres: Auteur is Pedro Rosa-Neto [Enlever les filtres]
Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking.. Front Hum Neurosci. 11:128.
.
2017. Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.. Front Aging Neurosci. 7:242.
.
2015. Consensus guidelines for lumbar puncture in patients with neurological diseases.. Alzheimers Dement (Amst). 8:111-126.
.
2017. Constrained instruments and their application to Mendelian randomization with pleiotropy.. Genet Epidemiol.
.
2019. Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset.. Neuroscience. 480:143-154.
.
2022. A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment.. Data Brief. 9:1122-1129.
.
2016. Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.. J Alzheimers Dis. 60(4):1589-1600.
.
2017. Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [¹⁸F]fluoroethoxybenzovesamicol.. Behav Brain Res. 278:107-14.
.
2015. Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome.. Proc Natl Acad Sci U S A. 113(41):11603-11608.
.
2016. Developments in Tau PET Imaging.. Can J Neurol Sci. 41(5):547-53.
.
2014. Does donepezil improve visual stimuli detection and perceptivo-cognitive performance of heathy young adults ? J Vis. 15(12):1133.
.
2015. The effects of exercise on sleep quality in persons with Parkinson's disease: A systematic review with meta-analysis.. Sleep Med Rev. 55:101384.
.
2020. Epistasis analysis links immune cascades and cerebral amyloidosis.. J Neuroinflammation. 12:227.
.
2015. Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients.. Continuum (Minneap Minn). 22(2 Dementia):615-8.
.
2016. FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry.. J Neuroimaging. 31(6):1077-1081.
.
2021. First-in-Human Brain Imaging of [F]TRACK, a PET tracer for Tropomyosin Receptor Kinases.. ACS Chem Neurosci. 10(6):2697-2702.
.
2019. Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.. Exp Gerontol.
.
2018. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, ε4, and Cognitive Impairment.. Neurology. 96(7):e975-e985.
.
2021. Frontal Variant of Alzheimer Disease Differentiated From Frontotemporal Dementia Using in Vivo Amyloid and Tau Imaging.. Cogn Behav Neurol. 33(4):288-293.
.
2020. Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research.. Alzheimers Dement (N Y). 6(1):e12085.
.
2020. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.. J Cereb Blood Flow Metab. 40(8):1576-1585.
.
2020. How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease? Neurodegener Dis. 13(2-3):197-9.
.
2014. Identification of [F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.. J Med Chem. 61(4):1737-1743.
.
2018. Identifying incipient dementia individuals using machine learning and amyloid imaging.. Neurobiol Aging. 59:80-90.
.
2017. Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.. Int Psychogeriatr. 26(5):703-7.
.
2014.